Navigation Links
Blacks With Certain Gene Need Lower Doses of Warfarin: Study
Date:6/5/2013

WEDNESDAY, June 5 (HealthDay News) -- The discovery of a genetic variation that affects how some black patients respond to the blood thinner warfarin could improve the safety and effectiveness of the drug, researchers report.

Blacks with this common genetic variation need a significantly lower dose of warfarin than those without the variation, the researchers report online June 4 in The Lancet.

"Adding this genetic marker -- found in more than 40 percent of African-American patients in the study -- to standard dosing algorithms improved the predictability of warfarin dosing by 21 percent in these individuals, which has the potential to increase the safety and effectiveness of this notoriously hard-to- dose drug," study leader Julie Johnson, of the University of Florida, said in a journal news release.

Warfarin is widely used to prevent blood clots in patients with a heart rhythm disorder called atrial fibrillation, a history of previous blood clots and after major surgery. However, it can be difficult to determine the correct dose for individual patients.

Previous research has identified two genes that explain about 30 percent of the difference in warfarin response in people of European and Asian ancestry, but these genes have less of an effect in blacks.

In this study, the researchers analyzed health information and DNA samples from hundreds of blacks and determined that there was a strong association between the rs12777823 variant on chromosome 10 and warfarin dose. The findings suggest that the dose of warfarin required by blacks with one or two copies of this variant is about 7 milligrams (mg) to 9 mg less per week than for other patients, the researchers said.

The U.S. Food and Drug Administration advocates use of genetic backgrounds to help guide warfarin dosing, Mark Alberts, of the University of Texas Southwestern Medical Center at Dallas and author of an accompanying editorial, said in the news release. "However, the practical aspects [and limitations] have not been fully appreciated.

"Genetic testing has several challenges: it is not widely available in some areas; it is costly; and clinicians often can identify the correct dose before test results are available. If these problems were corrected, the actual use of such tests might increase substantially," Alberts noted.

More information

The American Heart Association has more about warfarin.

-- Robert Preidt

SOURCE: The Lancet, news release, June 4, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. High Blood Pressure May Be Especially Lethal for Blacks
2. Hispanic lung cancer patients tend to live longer than blacks and whites
3. Blacks and Hispanics at higher risk for precancerous colorectal polyps
4. Blacks Less Likely to Get Help on Scene After Cardiac Arrest: Study
5. Eye Changes May Predict Heart Disease in Blacks With Diabetes
6. Blacks, Hispanics Have Higher Colon Polyp Risk Than Previously Thought
7. 9 in 10 Blacks With High Blood Pressure Have Early Heart Disease
8. Marriage has different meanings for blacks and whites
9. Blacks More Prone to Hypertension After Certain Strokes
10. Stress Adds to Salt Load of Some Blacks, Study Says
11. Blacks Less Likely to Stick to High Blood Pressure Diet: Study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blacks With Certain Gene Need Lower Doses of Warfarin: Study
(Date:8/20/2017)... ... ... total solar eclipse will occur across the U.S. on Monday, August 21, causing ... sun and Earth. This rare event will be magnificent to witness, but what does it ... the road during the total eclipse of the sun. , 1. Plan ahead. The eclipse’s ...
(Date:8/20/2017)... ... August 20, 2017 , ... ... HIPAA ComplyPAK™ Compliance Management System has assisted multiple clients in successfully passing ... Accountants, Service Organization Control Level 2 (AICPA SOC Level 2), and State Data ...
(Date:8/20/2017)... ... 20, 2017 , ... State Farm Neighborhood Assist® has named The Southern ... $25,000 grant. If the initiative wins, Gals Lead – Dream Queen Foundation’s signature teen ... area of St. Mary’s, Calvert and Charles Counties. The program could potentially impact nearly ...
(Date:8/20/2017)... CO (PRWEB) , ... August 20, 2017 , ... Are ... the same household? If so, you may be interested in participating in a ... purpose of this research is to understand more about the relational aspects of adults ...
(Date:8/19/2017)... ... August 19, 2017 , ... DMG Productions, producers of ... Group in an upcoming episode, slated to air fourth quarter 2017. Check your ... Aurum Group; a company committed to supporting dentistry using the most technologically advanced ...
Breaking Medicine News(10 mins):
(Date:8/18/2017)... Aug. 18, 2017  Nortis today announced the awarding of a $688K National ... the third year of a Small Business Innovation Research (SBIR)?Fast-track ... of Neurological Disorders and Stroke (NINDS).?  ... Nortis ParVivo Chip used ... ...
(Date:8/17/2017)... ANGELES , Aug. 17, 2017 MJAC2017 ... CBMJ – Canna Broadcast Media, today reveals its leading lineup. ... Isodiol International Inc., a global cannabis innovator specializing in the ... sponsor of the conference. MassRoots, Rambridge™ and The Green Organic ... Bay Inc. and Namaste Vapes™ as silver sponsors. ...
(Date:8/17/2017)... CAESAREA, Israel , August 17, 2017 /PRNewswire/ ... digital health Company with mobile health and big ... securities purchase agreements with domestic and non-U.S. investors ... common stock and shares of the Company,s newly ... private placement offerings. The Company expects to conduct ...
Breaking Medicine Technology: